— Know what they know.
Not Investment Advice
Also trades as: 001060.KS (KSC) · $vol 1M · 001065.KS (KSC) · $vol 0M

001067.KS KSC

JW Pharmaceutical Corporation
1W: +1.2% 1M: +4.5% 3M: +18.3% YTD: -13.4% 1Y: -18.5% 3Y: -12.1% 5Y: -22.0%
₩51,000.00 ($37.96)
+900.00 (+1.80%)
 
Weekly Expected Move ±3.1%
₩47828 ₩49414 ₩51000 ₩52586 ₩54172
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 61 · ₩471.7B mcap · 5M float · 0.0015% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap₩471.7B ($351.0M)
52W Range38500-61500
Volume19
Avg Volume76
Beta0.96
Dividend₩650.00
Analyst Ratings
No analyst coverage
Company Info
CEOYoung-Sub Shin
Employees1,106
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2005-09-29
JW Gwacheon Tower, 38
Gwacheon-si, GY 13840
KR
82 2 840 6777
About JW Pharmaceutical Corporation

JW Pharmaceutical Corporation operates as a global entity, actively involved in the creation, production, and distribution of a diverse range of pharmaceuticals and medical provisions. Its market reach extends internationally, with a significant presence in Japan. The company's extensive portfolio encompasses treatments across numerous therapeutic areas, including cardiovascular, gastrointestinal, urinary, and central nervous system health. It also addresses infectious diseases (such as those requiring antibiotics and antifungals), diabetes, obstetric and gynecological conditions, renal disorders, and respiratory ailments. Additionally, their offerings include medications for anemia, rheumatic arthritis, various cancers, anesthesia, antidotes, amino acid formulations, and Total Parenteral Nutrition (TPN). Founded in 1945, JW Pharmaceutical's corporate headquarters are located in Seoul, South Korea.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms